Markets

Celltrion Q2 Operating Income Jumps

July 03, 2026 — 04:02 am EDT

Written by RTTNews.com for RTTNews->

(RTTNews) - Celltrion, Inc. (068270.KS), a biopharmaceutical company, on Friday reported higher operating income and sales in the second quarter of 2026 compared with the same period last year.

For the second quarter, operating income also jumped to KRW 751.9 billion from KRW 391.9 billion

Sales for the period increased to KRW 2.45 trillion from KRW 1.80 trillion in the previous year.

Celltrion closed trading 3.96% higher at KRW 183,600 on the Korean Stock Exchange.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

  • •

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.